AI assistant
Sending…
Aurinia Pharmaceuticals Inc. — Director's Dealing 2021
May 12, 2021
31941_dirs_2021-05-12_b4c7cf14-5038-4a61-b2ef-cd3a7d64fb07.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aurinia Pharmaceuticals Inc. (AUPH)
CIK: 0001600620
Period of Report: 2021-05-11
Reporting Person: Leversage Jill (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-11 | Common Stock | P | 2500 | $10.9557 | Acquired | 3700 | Direct |
More from Aurinia Pharmaceuticals Inc.
Regulatory Filings
2026
May 11
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3